TrialClinical and translational science2023

First-in-human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS-penetrant soluble guanylyl cyclase stimulator.

Sebastiaan J W van Kraaij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.